Invention Grant
- Patent Title: Heterocyclic compounds and uses thereof
- Patent Title (中): 杂环化合物及其用途
-
Application No.: US13396339Application Date: 2012-02-14
-
Publication No.: US08865732B2Publication Date: 2014-10-21
- Inventor: Zilin Huang , Jeff Jin , Timothy Machajewski , William R. Antonios-McCrea , Maureen McKenna , Daniel Poon , Paul A. Renhowe , Martin Sendzik , Cynthia Shafer , Aaron Smith , Yongjin Xu , Qiong Zhang , Zheng Chen
- Applicant: Zilin Huang , Jeff Jin , Timothy Machajewski , William R. Antonios-McCrea , Maureen McKenna , Daniel Poon , Paul A. Renhowe , Martin Sendzik , Cynthia Shafer , Aaron Smith , Yongjin Xu , Qiong Zhang , Zheng Chen
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Scott W. Reid
- Main IPC: A61K31/505
- IPC: A61K31/505 ; C07D241/02
Abstract:
New substituted heterocyclic compounds, compositions containing them, and methods of using them for the inhibition of Raf kinase activity are provided. The new compounds and compositions may be used either alone or in combination with at least one additional agent for the treatment of a Raf kinase mediated disorder, such as cancer.
Public/Granted literature
- US20130210818A1 Novel Heterocyclic Compounds and Uses Thereof Public/Granted day:2013-08-15
Information query
